Cynata Therapeutics Limited
CYYNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,050 | $6,205 | $16,167 | $23,798 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $105 | $113 | $367 | $100 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $195 | $218 | $327 | $237 |
| Total Curr. Assets | $5,349 | $6,536 | $16,861 | $24,135 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,849 | $1,852 | $2,133 | $2,413 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,849 | $1,852 | $2,133 | $2,413 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,198 | $8,388 | $18,994 | $26,548 |
| Liabilities | – | – | – | – |
| Payables | $394 | $432 | $1,309 | $1,580 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $822 | $739 | $952 | $1,007 |
| Total Curr. Liab. | $1,216 | $1,171 | $2,260 | $2,588 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,216 | $1,171 | $2,260 | $2,588 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $89,519 | $81,625 | $81,625 | $74,900 |
| Retained Earnings | -$91,709 | -$82,319 | -$72,574 | -$58,296 |
| AOCI | $8,172 | $7,911 | $7,683 | $7,356 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $5,982 | $7,217 | $16,733 | $23,960 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,198 | $8,388 | $18,994 | $26,548 |
| Net Debt | -$5,050 | -$6,205 | -$16,167 | -$23,798 |